Published in RNA on March 01, 2002
LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol Cell Biol (2007) 1.79
The insertional history of an active family of L1 retrotransposons in humans. Genome Res (2004) 1.71
A natural allele of Nxf1 suppresses retrovirus insertional mutations. Nat Genet (2003) 1.67
Characterization of a synthetic human LINE-1 retrotransposon ORFeus-Hs. Mob DNA (2011) 0.98
Gammaretrovirus mRNA expression is mediated by a novel, bipartite post-transcriptional regulatory element. Nucleic Acids Res (2014) 0.89
Multipotent genetic suppression of retrotransposon-induced mutations by Nxf1 through fine-tuning of alternative splicing. PLoS Genet (2009) 0.89
HIV-1 and M-PMV RNA Nuclear Export Elements Program Viral Genomes for Distinct Cytoplasmic Trafficking Behaviors. PLoS Pathog (2016) 0.80
HIV Rev Assembly on the Rev Response Element (RRE): A Structural Perspective. Viruses (2015) 0.79
Diverse activities of viral cis-acting RNA regulatory elements revealed using multi-color, long-term, single cell imaging. Mol Biol Cell (2016) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Conserved structures and diversity of functions of RNA-binding proteins. Science (1994) 14.75
High frequency retrotransposition in cultured mammalian cells. Cell (1996) 8.60
The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J (2000) 7.54
The leucine-rich repeat: a versatile binding motif. Trends Biochem Sci (1994) 7.37
Many human L1 elements are capable of retrotransposition. Nat Genet (1997) 6.27
Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature (1988) 6.01
TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol Cell (1998) 5.85
Mex67p, a novel factor for nuclear mRNA export, binds to both poly(A)+ RNA and nuclear pores. EMBO J (1997) 5.61
The protein Aly links pre-messenger-RNA splicing to nuclear export in metazoans. Nature (2000) 5.57
Nuclear export of different classes of RNA is mediated by specific factors. J Cell Biol (1994) 4.99
The origin of interspersed repeats in the human genome. Curr Opin Genet Dev (1996) 4.80
The HIV-1 Rev protein. Annu Rev Microbiol (1998) 4.78
Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc Natl Acad Sci U S A (1990) 4.63
The Mex67p-mediated nuclear mRNA export pathway is conserved from yeast to human. EMBO J (1999) 4.49
A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci U S A (1994) 4.43
REF, an evolutionary conserved family of hnRNP-like proteins, interacts with TAP/Mex67p and participates in mRNA nuclear export. RNA (2000) 4.10
The C-terminal domain of TAP interacts with the nuclear pore complex and promotes export of specific CTE-bearing RNA substrates. RNA (2000) 3.96
Pre-mRNA splicing imprints mRNA in the nucleus with a novel RNA-binding protein that persists in the cytoplasm. Mol Cell (2000) 3.86
Yra1p, a conserved nuclear RNA-binding protein, interacts directly with Mex67p and is required for mRNA export. EMBO J (2000) 3.76
The impact of L1 retrotransposons on the human genome. Nat Genet (1998) 3.56
The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences. Genes Dev (1999) 3.24
Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Mol Cell (2001) 3.14
REF proteins mediate the export of spliced and unspliced mRNAs from the nucleus. Proc Natl Acad Sci U S A (2001) 3.10
The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J (1997) 3.10
Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J (1994) 3.02
The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export. Curr Biol (1997) 2.90
RNA recognition by RNP proteins during RNA processing. Annu Rev Biophys Biomol Struct (1998) 2.89
TAP binds to the constitutive transport element (CTE) through a novel RNA-binding motif that is sufficient to promote CTE-dependent RNA export from the nucleus. EMBO J (1999) 2.83
Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature (1988) 2.69
HnRNP L binds a cis-acting RNA sequence element that enables intron-dependent gene expression. Genes Dev (1995) 2.57
The structure of the mRNA export factor TAP reveals a cis arrangement of a non-canonical RNP domain and an LRR domain. EMBO J (2000) 2.44
Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol (1998) 2.40
Identification of novel import and export signals of human TAP, the protein that binds to the constitutive transport element of the type D retrovirus mRNAs. Mol Cell Biol (1999) 2.09
TAP (NXF1) belongs to a multigene family of putative RNA export factors with a conserved modular architecture. Mol Cell Biol (2000) 2.07
A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol Cell Biol (1997) 2.07
Domains of U4 and U6 snRNAs required for snRNP assembly and splicing complementation in Xenopus oocytes. EMBO J (1990) 1.96
Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. J Clin Invest (1993) 1.92
The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function. J Virol (1996) 1.85
Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J Virol (1996) 1.85
Overexpression of TAP/p15 heterodimers bypasses nuclear retention and stimulates nuclear mRNA export. J Biol Chem (2001) 1.84
Intronless mRNA transport elements may affect multiple steps of pre-mRNA processing. EMBO J (1999) 1.71
The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. J Virol (1993) 1.65
An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci U S A (1999) 1.59
cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K. J Virol (1999) 1.54
The mRNA export in Caenorhabditis elegans is mediated by Ce-NXF-1, an ortholog of human TAP/NXF and Saccharomyces cerevisiae Mex67p. RNA (2000) 1.52
Libraries for genomic SELEX. Nucleic Acids Res (1997) 1.48
NXT1 (p15) is a crucial cellular cofactor in TAP-dependent export of intron-containing RNA in mammalian cells. Mol Cell Biol (2001) 1.44
trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes. J Virol (1992) 1.42
The mouse histone H2a gene contains a small element that facilitates cytoplasmic accumulation of intronless gene transcripts and of unspliced HIV-1-related mRNAs. Proc Natl Acad Sci U S A (1997) 1.26
Identification of an RNA sequence within an intracisternal-A particle element able to replace Rev-mediated posttranscriptional regulation of human immunodeficiency virus type 1. J Virol (1997) 1.18
Structural and functional analysis of the avian leukemia virus constitutive transport element. RNA (1999) 1.08
Analysis of cellular factors that mediate nuclear export of RNAs bearing the Mason-Pfizer monkey virus constitutive transport element. J Virol (2000) 1.07
Rev protein and its cellular partners. Adv Pharmacol (2000) 1.06
Analysis of the RNA binding specificity of the human tap protein, a constitutive transport element-specific nuclear RNA export factor. Virology (1999) 1.04
Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure. J Virol (1991) 1.03
RNA polymerase III dependence of the human L1 promoter and possible participation of the RNA polymerase II factor YY1 in the RNA polymerase III transcription system. Nucleic Acids Res (1995) 0.99
Human L1 retrotransposition: insights and peculiarities learned from a cultured cell retrotransposition assay. Genetica (1999) 0.93
Splicing-independent expression of the herpes simplex virus type 1 thymidine kinase gene is mediated by three cis-acting RNA subelements. J Virol (1998) 0.89
Retroviral constitutive transport element evolved from cellular TAP(NXF1)-binding sequences. J Virol (2001) 0.88
Natural RNA circles function as efficient microRNA sponges. Nature (2013) 8.93
Self-assembly of a nanoscale DNA box with a controllable lid. Nature (2009) 4.62
miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J (2011) 3.55
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res (2009) 2.80
RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther (2006) 2.59
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nat Med (2010) 2.53
Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer (2011) 2.49
Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol (2005) 2.01
MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science (2013) 1.95
Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum. Blood (2012) 1.90
Crosstalk between mRNA 3' end processing and transcription initiation. Mol Cell (2010) 1.89
Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses. J Immunol (2002) 1.89
Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol (2007) 1.87
A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity. Nucleic Acids Res (2009) 1.84
Circular RNA and miR-7 in cancer. Cancer Res (2013) 1.79
A 5' splice site enhances the recruitment of basal transcription initiation factors in vivo. Mol Cell (2008) 1.74
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials (2007) 1.65
Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Natl Acad Sci U S A (2007) 1.60
Improved silencing properties using small internally segmented interfering RNAs. Nucleic Acids Res (2007) 1.53
Single-molecule chemical reactions on DNA origami. Nat Nanotechnol (2010) 1.52
Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol (2009) 1.52
DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J Virol (2005) 1.52
RNA interactions in the 5' region of the HIV-1 genome. J Mol Biol (2004) 1.51
Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet (2007) 1.50
A microRNA detection system based on padlock probes and rolling circle amplification. RNA (2006) 1.49
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. PLoS One (2012) 1.48
Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity. J Biol Chem (2007) 1.47
Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol Ther (2008) 1.47
A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine (2005) 1.45
DNA origami design of dolphin-shaped structures with flexible tails. ACS Nano (2008) 1.43
PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression. Mol Cell Biol (2003) 1.43
Enhancing miRNA annotation confidence in miRBase by continuous cross dataset analysis. RNA Biol (2011) 1.40
Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J Exp Med (2010) 1.40
Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors. ACS Nano (2009) 1.38
Comparative genomics beyond sequence-based alignments: RNA structures in the ENCODE regions. Genome Res (2007) 1.37
Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes. J Immunol (2006) 1.36
A novel approach to describe a U1 snRNA binding site. Nucleic Acids Res (2003) 1.35
The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice. Mol Ther (2009) 1.35
Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation. Vaccine (2008) 1.34
Photonic-crystal waveguide biosensor. Opt Express (2007) 1.31
DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc Natl Acad Sci U S A (2009) 1.30
Role of the trans-activation response element in dimerization of HIV-1 RNA. J Biol Chem (2004) 1.28
Dimerization and template switching in the 5' untranslated region between various subtypes of human immunodeficiency virus type 1. J Virol (2003) 1.26
An unusual topological structure of the HIV-1 Rev response element. Cell (2013) 1.26
A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects. Nucleic Acids Res (2010) 1.26
DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge. Proc Natl Acad Sci U S A (2013) 1.25
The strength of the HIV-1 3' splice sites affects Rev function. Retrovirology (2006) 1.24
SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses. Vaccine (2011) 1.23
Defining a 5' splice site by functional selection in the presence and absence of U1 snRNA 5' end. RNA (2002) 1.23
MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS One (2011) 1.23
Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques. J Immunol (2008) 1.22
Regulated HIV-2 RNA dimerization by means of alternative RNA conformations. Nucleic Acids Res (2002) 1.20
U2AF participates in the binding of TAP (NXF1) to mRNA. J Biol Chem (2001) 1.18
A distant cis acting intronic element induces site-selective RNA editing. Nucleic Acids Res (2012) 1.14
RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway. J Biol Chem (2006) 1.14
Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine (2010) 1.13
Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure. J Virol (2013) 1.12
Nuclear export factor family protein participates in cytoplasmic mRNA trafficking. J Biol Chem (2005) 1.09
Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo. Mol Biosyst (2010) 1.07
A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds. Sci Rep (2013) 1.07
The RNA-binding motif protein 15B (RBM15B/OTT3) acts as cofactor of the nuclear export receptor NXF1. J Biol Chem (2009) 1.06
Molecular strategies to inhibit HIV-1 replication. Retrovirology (2005) 1.05
Ratjadones inhibit nuclear export by blocking CRM1/exportin 1. Exp Cell Res (2003) 1.05
The RNA transport element of the murine musD retrotransposon requires long-range intramolecular interactions for function. J Biol Chem (2010) 1.04
Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization. J Virol (2006) 1.03
HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques. Vaccine (2013) 1.03
Delivery of siRNA from lyophilized polymeric surfaces. Biomaterials (2007) 1.03
Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J Virol (2010) 1.03
HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice. PLoS One (2013) 1.03
IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques. Hum Vaccin Immunother (2012) 1.02
Cantilever sensor for nanomechanical detection of specific protein conformations. Nano Lett (2005) 1.02
Chemical modification of small interfering RNA. Methods Mol Biol (2011) 1.02
Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus. Virology (2006) 1.02
Semiautomated improvement of RNA alignments. RNA (2007) 1.02
siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells. Mol Ther (2010) 1.00
Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFα prevents radiation-induced fibrosis. Radiother Oncol (2010) 0.99
Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice. Vaccine (2005) 0.99
Multithreaded comparative RNA secondary structure prediction using stochastic context-free grammars. BMC Bioinformatics (2011) 0.99
Evaluating the accuracy of SHAPE-directed RNA secondary structure predictions. Nucleic Acids Res (2013) 0.99
Nanocarrier stimuli-activated gene delivery. Small (2007) 0.98
PPfold 3.0: fast RNA secondary structure prediction using phylogeny and auxiliary data. Bioinformatics (2012) 0.98
Identification and characterization of the mouse nuclear export factor (Nxf) family members. Nucleic Acids Res (2005) 0.98
Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines. Vaccine (2008) 0.98
Optimized siRNA-PEG conjugates for extended blood circulation and reduced urine excretion in mice. Theranostics (2013) 0.97
Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques. Vaccine (2010) 0.96
Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes. Vaccine (2011) 0.96
RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs. Retrovirology (2006) 0.96
Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA. Nucleic Acids Res (2009) 0.96
Synthesis of 2'-O-modified adenosine building blocks and application for RNA interference. Bioorg Med Chem (2007) 0.96
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering. Front Genet (2012) 0.95
The p40 subunit of interleukin (IL)-12 promotes stabilization and export of the p35 subunit: implications for improved IL-12 cytokine production. J Biol Chem (2013) 0.95
Construction of a 4 zeptoliters switchable 3D DNA box origami. ACS Nano (2012) 0.94
Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer. J Biol Chem (2013) 0.94
Polycation-based nanoparticle delivery for improved RNA interference therapeutics. Expert Opin Biol Ther (2007) 0.94
MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93. Cell Oncol (Dordr) (2011) 0.93
A novel splice donor site in the gag-pol gene is required for HIV-1 RNA stability. J Biol Chem (2006) 0.93